Insulinomas, the most common functional neuroendocrine tumours of the pancreas, are usually sporadic, benign and solitary.
RESULTS: Median duration of hyperinsulinemia= 2 years;
Sporadic insulinomas : 23 patients (92%); MEN 1 syndrome: 2 patients (8%); Hepatic metastases: 2 patients (8%).
CONCLUSION:
Partial pancreatectomy or enucleation provided a good cure rate in patients with pre-operative localized insulinomas.
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OUTCOME OF INSULINOMAS DIAGNOSED IN A TERTIARY ENDOCRINE CENTER AIMS:
To assess biochemical data, localization and treatment outcome of insulinomas diagnosed in a tertiary endocrine center. Surgery: enucleation / cephalic duodenopancreatectomy /distal pancreatectomy);
Medical treatment (diazoxide 200-300 mg/day or somatostatin analogues) were used in non-cured patients to control hypoglycemia. 
